|
시장보고서
상품코드
2141396
배양육 원료 시장 기회, 성장 촉진요인, 업계 동향 분석 및 예측(2026-2035년)Cultivated Meat Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
세계의 배양육 원료 시장은 2025년에 1억 8,400만 달러 규모에 달하고, CAGR 4.7%로 성장하여 2035년까지 2억 9,240만 달러에 달할 것으로 추정됩니다.
| 시장 범위 | |
|---|---|
| 시작 연도 | 2025년 |
| 예측 기간 | 2026-2035년 |
| 초기 시장 규모 | 1억 8,400만 달러 |
| 예측액 | 2억 9,240만 달러 |
| CAGR | 4.7% |
Global Market Insights Inc.가 발표한 최신 보고서에 따르면, 배양육 원료 산업은 연구용 실험실 등급의 재료에서 파일럿 규모 및 상업적 생산에 적합한 식품 적합성 원료로 전환되고 있습니다. 이 시장에서는 바이오리액터에 대한 투자나 배양육 완제품의 매출이 아니라, 세포 배양용 원료, 스캐폴드용 생체 재료 및 배합 원료에서 발생하는 공급업체의 수익을 측정 대상으로 삼고 있습니다. 이러한 구분은 중요한 의미를 지닙니다. 왜냐하면 벤처 자금 조달 환경이 여전히 엄격한 상황에서도, 특히 가동중인 시설이 배지 배합 및 조직 개발 공정을 정교하게 다듬어 나감에 따라 원료 조달량은 계속 증가할 가능성이 있기 때문입니다. 제조업체와 기술 개발자들은 원료의 품질, 확장성, 일관성, 그리고 식품 생산에 대한 적합성 향상에 점점 더 집중하고 있습니다. 세포 배양 및 조직 공학의 발전으로 인해 배양육 제조업체들이 생산 효율과 상용화 준비 태세 향상에 주력함에 따라, 전문 원료 공급업체들에게 새로운 기회가 생겨나고 있습니다. 업계가 초기 연구 단계에서 대규모 생산으로 전환됨에 따라, 비용 효율적이고 식품에 적합한 배합 개발이 점점 더 중요해지고 있습니다. 이러한 추세에 힘입어 2035년까지 배양육 원료 시장은 꾸준한 성장을 이어갈 것으로 예상됩니다.
2025년, 배양 배지 성분 부문의 시장 규모는 1억 1,590만 달러에 달했습니다. 이러한 재료는 세포 배양 공정의 기초를 이루며, 기초 배지, 혈청 대체제, 재조합 성장 인자, 아미노산, 비타민 등이 필수적인 소모품으로 기능하고 있습니다. 배양육 개발 기업들이 효율적인 세포 증식과 조직 형성을 뒷받침할 신뢰할 수 있는 배합을 추구하고 있기 때문에 세포 증식 조건의 지속적인 최적화가 이러한 원자재에 대한 수요를 지탱하고 있습니다. 또한, 안정적인 성능과 식품 적합성을 갖춘 원료에 대한 수요가 높아짐에 따라, 각 공급업체들은 새로운 배양육 생산 요건에 맞춰 제품 라인업을 개선하고 있습니다.
2025년에는 가금류 배양 부문이 시장 점유율의 42%를 차지했으며, 2035년까지 연평균 성장률(CAGR) 4.2%로 성장할 것으로 전망됩니다. 배양 닭고기는 싱가포르와 미국에서의 조기 규제 승인을 바탕으로, 비교적 성숙한 원료 공급 생태계의 혜택을 받고 있습니다. 확립된 무혈청 배지 시스템의 가용성도 가금류 세포 배양 워크플로우에 견고한 기반을 제공하고 있습니다. 생산자들이 확장 가능한 배양 공정 개발을 계속함에 따라, 가금류 용도를 둘러싼 확립된 원료 인프라는 특수 배지 성분 및 기타 배양 자재에 대한 지속적인 수요를 뒷받침할 것으로 예상됩니다.
북미 배양육 원료 시장은 2025년에 40%의 점유율을 차지했으며, 2035년까지 연평균 성장률(CAGR) 4%로 성장할 것으로 전망됩니다. 미국은 주요 원료 공급업체의 존재, 활발한 배양육 기업의 활동, 그리고 확립된 FDA/USDA 규제 절차에 힘입어 지역 수요의 대부분을 차지하고 있습니다. 공급업체의 역량, 생산 활동, 규제 체계의 정비, 그리고 지속적인 투자가 어우러져 배양육 원료 채택에 유리한 환경이 조성되고 있습니다. 상업적 생산능력의 지속적인 개발을 통해 예측 기간 동안 북미가 해당 지역에서 주도적인 위치를 유지할 것으로 전망됩니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 업계 인사이트
제4장 경쟁 구도
제5장 시장 추정 및 예측 : 성분별, 2023-2035년
제6장 시장 추정 및 예측 : 용도별, 2023-2035년
제7장 시장 추정 및 예측 : 최종 용도별, 2023-2035년
제8장 시장 추정 및 예측 : 지역별, 2023-2035년
제9장 기업 개요
KSM 26.10.13The Global Cultivated Meat Ingredients Market was valued at USD 184 million in 2025 and is estimated to grow at a CAGR of 4.7% to reach USD 292.4 million by 2035.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $184 Million |
| Forecast Value | $292.4 Million |
| CAGR | 4.7% |
According to the latest report published by Global Market Insights Inc., the cultivated meat ingredients industry is undergoing a shift from research-focused, laboratory-grade materials toward food-compatible inputs suitable for pilot-scale and commercial manufacturing. The market measures supplier revenue generated from cell-culture raw materials, scaffold biomaterials, and formulation inputs rather than spending on bioreactors or sales of finished cultivated meat products. This distinction is important because ingredient procurement can continue increasing even when venture funding remains selective, particularly as operating facilities refine their media formulations and tissue-development processes. Manufacturers and technology developers are increasingly focused on improving ingredient quality, scalability, consistency, and suitability for food production. Advances in cell culture and tissue engineering are creating opportunities for specialized ingredient suppliers as cultivated meat producers work to improve production efficiency and commercial readiness. The development of cost-effective, food-compatible formulations is becoming increasingly important as the industry moves beyond early-stage research toward larger-scale production. These trends are expected to support steady expansion of the cultivated meat ingredients market through 2035.
Growth media components segment held USD 115.9 million in 2025. These materials form a fundamental part of cell-culture processes, with basal media, serum alternatives, recombinant growth factors, amino acids, and vitamins serving as essential consumables. Continued optimization of cell-growth conditions is sustaining demand for these inputs as cultivated meat developers seek reliable formulations that can support efficient cell expansion and tissue development. The need for consistent performance and food-compatible ingredients is also encouraging suppliers to refine their product offerings for emerging cultivated meat production requirements.
Poultry cultivation segment accounted for 42% share in 2025 and is forecast to grow at a CAGR of 4.2% through 2035. Cultivated chicken benefits from a relatively mature ingredient-supply ecosystem, supported by earlier regulatory approvals in Singapore and the United States. The availability of established serum-free media systems also provides a stronger foundation for poultry cell-culture workflows. As producers continue developing scalable cultivation processes, the established ingredient infrastructure surrounding poultry applications is expected to support continued demand for specialized media components and other cultivation inputs.
North America Cultivated Meat Ingredients Market captured 40% share in 2025 and is forecast to grow at a CAGR of 4% through 2035. The United States represents the majority of regional demand, supported by the presence of leading ingredient suppliers, active cultivated meat companies, and an established FDA/USDA regulatory pathway. The combination of supplier capabilities, production activity, regulatory development, and ongoing investment is creating a favorable environment for the adoption of cultivated meat ingredients. Continued development of commercial production capabilities is expected to maintain North America's leading regional position throughout the forecast period.
Major companies operating in the global cultivated meat ingredients market include Ajinomoto, Sartorius, Bio-Techne, Merck KGaA, and Thermo Fisher Scientific. Companies are strengthening their foothold in the global cultivated meat ingredients market through research and development, formulation optimization, portfolio expansion, and strategic collaborations. Suppliers are concentrating on developing food-compatible ingredients that can deliver consistent performance while supporting larger-scale cell-culture operations. Investments in serum alternatives, growth factors, media formulations, and specialized biomaterials are helping companies address the evolving technical requirements of cultivated meat producers. Businesses are also working to improve scalability and production efficiency so that ingredient costs can become more suitable for commercial applications. Partnerships with cultivated meat developers and research organizations enable suppliers to refine products according to specific cell-culture requirements and accelerate commercialization. Expanding production capabilities and strengthening supply chains are further helping companies improve reliability and meet future demand. Providers are also focusing on regulatory readiness, quality consistency, technical support, and customized formulations to differentiate their offerings. These strategies allow market participants to build stronger customer relationships, expand their application reach, and establish long-term positions as cultivated meat production moves toward broader commercialization.
Table of Contents
Chapter 1. Methodology & Scope
- 1.1 Market scope and definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
- 1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.6 Forecast model
- 1.7 Research assumptions and limitations
Chapter 2. Executive Summary
- 2.1 Industry 360° synopsis
- 2.2 Key market trends
- 2.2.1 Ingredients trends
- 2.2.2 Application trends
- 2.2.3 End use trends
- 2.2.4 Regional trends
- 2.3 TAM Analysis, 2026-2035
- 2.4 CXO perspectives: Strategic imperatives
- 2.4.1 Executive decision points
- 2.4.2 Critical success factors
- 2.5 Future Outlook and Strategic Recommendations
Chapter 3. Industry Insights
- 3.1 Industry ecosystem analysis
- 3.1.1 Supplier landscape
- 3.1.2 Profit margin
- 3.1.3 Value addition at each stage
- 3.1.4 Factor affecting the value chain
- 3.1.5 Disruptions
- 3.2 Industry impact forces
- 3.2.1 Drivers
- 3.2.2 Pitfalls & Challenges
- 3.2.3 Opportunities
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
- 3.4.4 Latin America
- 3.4.5 Middle East & Africa
- 3.5 Porter’s analysis
- 3.6 PESTEL analysis
- 3.7 Price trends
- 3.7.1 By region
- 3.7.2 By ingredients
- 3.8 Future market trends
- 3.9 Technology and Innovation landscape
- 3.9.1 Current technological trends
- 3.9.2 Emerging technologies
- 3.10 Patent Landscape
- 3.11 Trade statistics (HS code) (Note: the trade statistics will be provided for key countries only)
- 3.11.1 Major importing countries
- 3.11.2 Major exporting countries
- 3.12 Sustainability and environmental aspects
- 3.12.1 Sustainable practices
- 3.12.2 Waste reduction strategies
- 3.12.3 Energy efficiency in production
- 3.12.4 Eco-friendly initiatives
- 3.13 Carbon footprint consideration
Chapter 4. Competitive Landscape, 2025
- 4.1 Introduction
- 4.2 Company market share analysis
- 4.2.1 By region
- 4.2.1.1 North America
- 4.2.1.2 Europe
- 4.2.1.3 Asia Pacific
- 4.2.1.4 LATAM
- 4.2.1.5 MEA
- 4.2.1 By region
- 4.3 Company matrix analysis
- 4.4 Competitive analysis of major market players
- 4.5 Competitive positioning matrix
- 4.6 Key developments
- 4.6.1 Mergers & acquisitions
- 4.6.2 Partnerships & collaborations
- 4.6.3 New Product Launches
- 4.6.4 Expansion Plans
Chapter 5. Market Estimates and Forecast, By Ingredients, 2023-2035 (USD Million & Kilo Tons)
- 5.1 Key trends
- 5.2 Growth media components
- 5.2.1 Basal media
- 5.2.2 Serum & serum alternatives
- 5.2.3 Recombinant growth factors
- 5.2.4 Recombinant structural & functional proteins
- 5.2.5 Amino acids & nitrogen sources
- 5.2.6 Vitamins, minerals & energy sources
- 5.3 Growth media components
- 5.3.1 Nanofibrous scaffolds
- 5.3.2 Edible microcarriers
- 5.3.3 Edible membranes & hollow fiber systems
- 5.3.4 Extracellular matrix (ECM) proteins
- 5.3.5 Plant-derived scaffolds
- 5.3.6 Fungal & microbial scaffolds
- 5.3.7 Synthetic polymer scaffolds
- 5.3.8 3D bioinks
- 5.4 Processing aids & formulation ingredients
- 5.4.1 Crosslinking enzymes
- 5.4.2 Lipids & fatty acids
- 5.4.3 Emulsifiers & stabilizers
- 5.4.4 Fat substitutes & oleogels
- 5.4.5 Flavor systems & sensory enhancers
Chapter 6. Market Estimates and Forecast, By Application, 2023-2035 (USD Million & Kilo Tons)
- 6.1 Key trends
- 6.2 Poultry cultivation
- 6.3 Seafood & fish cultivation
- 6.4 Beef & red meat cultivation
- 6.5 Pork cultivation
- 6.6 Exotic & novel meats
- 6.7 Others
Chapter 7. Market Estimates and Forecast, By End Use, 2023-2035 (USD Million & Kilo Tons)
- 7.1 Key trends
- 7.2 Commercial Cultivated Meat Producers
- 7.3 Pilot & Demonstration Facilities
- 7.4 Research Institutions & Academia
- 7.5 Others
Chapter 8. Market Estimates and Forecast, By Region, 2023-2035 (USD Million & Kilo Tons)
- 8.1 Key trends
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
- 8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa
Chapter 9. Company Profiles
- 9.1 Thermo Fisher Scientific
- 9.2 Merck KGaA
- 9.3 Bio-Techne
- 9.4 Ajinomoto
- 9.5 Evonik Industries
- 9.6 CJ Bio
- 9.7 Wacker Chemie
- 9.8 Sartorius
- 9.9 ADM
- 9.10 Cargill
- 9.11 GenScript
- 9.12 Takara Bio
- 9.13 Rousselot
- 9.14 GELITA
- 9.15 Palsgaard
